Home > News > Public Health Updated 23 January 2014 Igniting Healthcare Innovation in Africa The UCT Graduate School of Business and the UCT Faculty of Health Sciences are looking for a needs-based approach to healthcare innovation in Africa. 0 Inclusive Healthcare Innovation Initiative ~ Related A breakthrough in diagnostic tech Pioneering operation at Netcare Christiaan Barnard Memorial Hospital Gauteng hospitals face billions in claims A new platform for Africans to tackle health on the continent that will focus on generating creative and innovative solutions that cut across disciplines and sectors has been launched by the University of Cape Town.The Inclusive Healthcare Innovation Initiative (IHII), is a joint initiative of the UCT Graduate School of Business (GSB) and the UCT Faculty of Health Sciences. Health24.com is the official media partner of the initiative.The IHII will serve as a collaborative, cross-sectoral and trans-disciplinary platform and promote a needs-based, empathy-driven approach to healthcare innovation. Support for the initiative has been received from the National Department of Health and of Science and Technology, the South African Medical Research Council, and the Technology Innovation Agency.To mark the launch of the Initiative, UCT will host two landmark events:The Hacking Health 2014 healthcare innovation hackathon in Cape Town on 24 & 25 January 2014. The Inclusive Health Care Innovation Summit in Cape Town on 29 & 30 January 2014. The launch of the IHII comes at a time when health care in South Africa and Africa is facing a myriad of challenges in delivering care to those who need it most.“The complexity of challenges faced in healthcare is calling for different paradigms of thinking and for the co-creation of new innovative solutions,” says Professor de Villiers, Dean, UCT Faculty of Health Sciences. “Now more than ever innovation is required to develop solutions that can improve the delivery of healthcare in Africa in an inclusive, effective and affordable manner. These solutions must transcend current challenges in the system to improve health outcomes for patients but also to change the routines, responsibility and values of our health workers responsible for delivering the care.” Director of the GSB, Professor Walter Baets says, “Together with the initiative’s partners, participants of the summit, and actors in the healthcare system, new innovative solutions for a healthier African future can be pioneered.”The IHII will be based in the Bertha Centre for Social Innovation and Entrepreneurship at the GSB and in the Department of Medicine at UCT and Groote Schuur Hospital. For any queries about the Initiative please contact Dr Lindi van Niekerk at firstname.lastname@example.org / Tel: 072 236 2079Registrations for the Inclusive Healthcare Innovation Summit are now open! To register go to www.inclusivehealth.co.za. Press Release, University of Cape Town Bertha Centre for Social Innovation and Entrepreneurship NEXT ON HEALTH24X Coronavirus in SA: All the confirmed cases 2020-03-12 13:35 More: NewsPublic Health advertisement Read Health24’s Comments Policy Comment on this story 0 comments Comments have been closed for this article. Logout Comment 0 characters remaining Share on Facebook Loading comments... Other news Medical Coronavirus in SA: All the confirmed cases Medical Latest on Covid-19 testing in SA: Public sector backlogs more than 6 days – an expert tells us more Medical Human trial of a coronavirus vaccine shows safe and promising results Medical Covid-19 antibodies may tame inflammatory condition in kids Medical More insight into the cytokine storm caused by Covid-19 could lead to a treatment Medical Experimental vaccines shield monkeys from coronavirus Live healthier Lifestyle » E-cigarettes: Here are five things to know E-cigarettes have become hugely popular in the past decade, but a rash of vaping-linked deaths and illnesses in the US is feeding caution about a product that's already banned in some places. Allergy » Ditch the itch: Researchers find new drug to fight hives A new drug works by targeting an immune system antibody called immunoglobulin E, which is responsible for the allergic reaction that causes hives.